Related references
Note: Only part of the references are listed.Should organs at risk (OARs) be prioritized over target volume coverage in stereotactic ablative radiotherapy (SABR) for oligometastases? a secondary analysis of the population-based phase II SABR-5 trial
Reno Eufemon Cereno et al.
RADIOTHERAPY AND ONCOLOGY (2023)
Survival After Adrenalectomy for Metastatic Lung Cancer
Lauren N. Krumeich et al.
ANNALS OF SURGICAL ONCOLOGY (2022)
Determining Planning Priorities for SABR for Oligometastatic Disease: A Secondary Analysis of the SABR-COMET Phase II Randomized Trial
Matthew Van Oirschot et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)
Association of Radiation Therapy With Risk of Adverse Events in Patients Receiving Immunotherapy A Pooled Analysis of Trials in the US Food and Drug Administration Database
Mitchell S. Anscher et al.
JAMA ONCOLOGY (2022)
Treatment patterns for adrenal metastases using surgery and SABR during a 10-year period
Claire van Vliet et al.
RADIOTHERAPY AND ONCOLOGY (2022)
eLocal Therapy for Oligometastatic Disease-Cart Before the Horse?
Puneeth Iyengar
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)
Impact of daily plan adaptation on organ-at-risk normal tissue complication probability for adrenal lesions undergoing stereotactic ablative radiation therapy
Hanbo Chen et al.
RADIOTHERAPY AND ONCOLOGY (2021)
Modeling of Tumor Control Probability in Stereotactic Body Radiation Therapy for Adrenal Tumors
Priscilla K. Stumpf et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
Stereotactic Body Radiation Therapy of Adrenal Metastases: A Pooled Meta-Analysis and Systematic Review of 39 Studies with 1006 Patients
William C. Chen et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Prognostic factors after adrenalectomy for adrenal metastasis
A. Goujon et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2020)
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
Yolande Lievens et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial
David A. Palma et al.
BMC CANCER (2019)
Role of Daily Plan Adaptation in MR-Guided Stereotactic Ablative Radiation Therapy for Adrenal Metastases
Miguel A. Palacios et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Effect of Stereotactic Body Radiotherapy on the Growth Kinetics and Enhancement Pattern of Primary Renal Tumors
Maryellen R. M. Sun et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2016)
Consensus statement from the International Radiosurgery Oncology Consortium for Kidney for primary renal cell carcinoma
Shankar Siva et al.
FUTURE ONCOLOGY (2016)
Vertebral fractures - An underestimated side-effect in patients treated with radio(chemo)therapy
Karoline Pilz et al.
RADIOTHERAPY AND ONCOLOGY (2016)